SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062018
Filing Date
2023-11-09
Accepted
2023-11-09 16:06:40
Documents
64
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q inab-20230930.htm   iXBRL 10-Q 2075726
2 EX-31.1 inab-ex31_1.htm EX-31.1 21136
3 EX-31.2 inab-ex31_2.htm EX-31.2 20516
4 EX-32.1 inab-ex32_1.htm EX-32.1 19706
5 GRAPHIC img238866828_0.jpg GRAPHIC 21241
  Complete submission text file 0000950170-23-062018.txt   6991243

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inab-20230930_cal.xml EX-101.CAL 42198
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inab-20230930_pre.xml EX-101.PRE 302023
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inab-20230930_def.xml EX-101.DEF 138971
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inab-20230930.xsd EX-101.SCH 47773
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inab-20230930_lab.xml EX-101.LAB 400097
58 EXTRACTED XBRL INSTANCE DOCUMENT inab-20230930_htm.xml XML 1044138
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39692 | Film No.: 231392349
SIC: 2836 Biological Products, (No Diagnostic Substances)